CN101020028A - Chinese medicine for treating cardiac and cerebral vascular diseases - Google Patents
Chinese medicine for treating cardiac and cerebral vascular diseases Download PDFInfo
- Publication number
- CN101020028A CN101020028A CNA2006101510257A CN200610151025A CN101020028A CN 101020028 A CN101020028 A CN 101020028A CN A2006101510257 A CNA2006101510257 A CN A2006101510257A CN 200610151025 A CN200610151025 A CN 200610151025A CN 101020028 A CN101020028 A CN 101020028A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- rhizoma
- vascular diseases
- cerebral vascular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The Chinese medicine for treating cardiac and cerebral vascular diseases is prepared with American ginseng, astragalus root, angelica, leatherleaf milletia, saffron and other 23 kinds of Chinese medicinal materials. It has the functions of dilating blood vessel, antagonizing coagulation, eliminating thrombus, improving blood circulation, etc. It is used in treating coronary heart disease, angina, myocardial ischemia and other cardiac and cerebral vascular diseases. It has the advantages of short treating period, fast acting, no resistance, no toxic side effect and high effective rate.
Description
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease.
Background technology
Cardiovascular and cerebrovascular disease is meant cardio cerebrovascular affection and then causes the disease of heart and brain tissues blood supply disorder.Heart disease mainly shows as coronary heart disease and angina pectoris.Cerebrovascular mainly shows as hemorrhagic apoplexy and ischemic cerebrovascular.And cardiovascular and cerebrovascular disease such as cerebral arteriosclerosis, coronary heart disease, angina pectoris, cerebral thrombosis, cerebral infarction, cerebral hemorrhage has become healthy frequently-occurring disease of a kind of serious harm middle-aged and elderly people and common property disease.Therefore the prevention of cardiovascular and cerebrovascular disease and treatment have become the important topic of society and medical circle concern.Treat the compound medicines function singleness of cardiovascular and cerebrovascular disease at present, slow curative effect.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease, short treating period, instant effect, no Drug resistance and toxic and side effects.
Medicine of the present invention is monarch with QI replenishing and blood harmonizing benefit blood medicine, and choosing is with Radix Panacis Quinquefolii, the Radix Astragali, XIGUI, Caulis Spatholobi; With blood circulation promoting and blood stasis dispelling, Pimobendane is minister, selects Radix Notoginseng, Stigma Croci, Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, Radix Paeoniae Rubra, Semen Persicae, Ramulus Cinnamomi for use; Assistant with anticoagulant thromboembolism preventing thrombolytic, activate self streptokinase medicine, select Hirudo, Pheretima, Agkistrodon, Scorpio, Scolopendra for use; Make with blood fat reducing, fall blood thickness, cholesterol reducing, hypotensor, choosing is with Fructus Crataegi, Ramulus Uncariae Cum Uncis, Rhizoma Gastrodiae, Radix Curcumae, the Radix Aucklandiae, Rhizoma Alismatis, Flos Sophorae, Radix Sophorae Flavescentis, Radix Puerariae, Semen Cassiae; Be aided with drugs of causing resuscitation by administering aromatic drugs again, priming penetrates blood brain barrier, and through sick medicine is selected Moschus and Borneolum Syntheticum for use.
Use Chinese medicine of the present invention, blood vessel dilating, activates self streptokinase, blood fat reducing, falls blood thickness, cholesterol reducing, blood pressure lowering, mediation blood vessels, improves blood circulation anticoagulant thromboembolism preventing, thrombolysis and thrombus diminishing, change bolt row bolt.Cure mainly coronary heart disease, angina pectoris, myocardial ischemia, myocardial infarction, arrhythmia, atrial fibrillation, cardiovascular disease such as cardiopalmus heart beating, chest pain are weak, sensation of oppression over the chest with shortness of breath, rich, vexed, insomnia early, night sweat and paroxysmal pareordia breastbone pain.Apoplexy, cerebral thrombosis, cerebral embolism, cerebral infarction, brain atrophy, cerebral blood supply insufficiency, cerebral hemorrhage are lost cerebrovascular disease such as disease, hemiplegia.Diseases such as hyperlipidemia, hypertension, high blood viscosity are thick, hypercholesterolemia, arteriosclerosis.
Chinese medicine of the present invention is made by the crude drug of following weight ratio: Radix Panacis Quinquefolii 5-8%, Radix Astragali 10-16%, XIGUI 3-5%, Caulis Spatholobi 3-5%, Stigma Croci 1-3%, Radix Notoginseng 3-5%, Radix Salviae Miltiorrhizae 4-6%, Rhizoma Chuanxiong 6-12%, Radix Paeoniae Rubra 3-6%, Semen Persicae 3-6%, Ramulus Cinnamomi 3-6%, Hirudo 2-4%, Pheretima 4-6%, Agkistrodon 3-6%, Scorpio 1.5-3%, Scolopendra 1-3%, Fructus Crataegi 3-6%, Ramulus Uncariae Cum Uncis 3-6%, Rhizoma Gastrodiae 2-3%, Radix Curcumae 3-6%, Radix Aucklandiae 1.5-3%, Rhizoma Alismatis 2-3%, Flos Sophorae 3-5%, Radix Sophorae Flavescentis 3-5%, Radix Puerariae 3-5%, Semen Cassiae 3-5%, Moschus 0.1-0.15%, Borneolum Syntheticum 0.8-1.5%.
Preparation method: pulverization make capsule or routinely pharmaceutical methods make tablet or other dosage form.
The specific embodiment
Preferably: Radix Panacis Quinquefolii 6%, the Radix Astragali 12%, XIGUI 3.6%, Caulis Spatholobi 3.6%, Stigma Croci 1.2%, Radix Notoginseng 3.6%, Radix Salviae Miltiorrhizae 5%, Rhizoma Chuanxiong 7.2%, Radix Paeoniae Rubra 3.6%, Semen Persicae 3.6%, Ramulus Cinnamomi 3.6%, Hirudo 2.4%, Pheretima 5%, Agkistrodon 3.6%, Scorpio 1.8%, Scolopendra 1.2%, Fructus Crataegi 3.6%, Ramulus Uncariae Cum Uncis 3.6%, Rhizoma Gastrodiae 2.5%, Radix Curcumae 3.6%, the Radix Aucklandiae 1.8%, Rhizoma Alismatis 2.5%, Flos Sophorae 3.6%, Radix Sophorae Flavescentis 3.6%, Radix Puerariae 3.6%, Semen Cassiae 3.6%, Moschus 0.1%, Borneolum Syntheticum 0.9%.Pulverization is made capsule or tablet.Take 10g at every turn, obey every day 3 times.
Below by clinical observation test, further set forth the beneficial effect of Chinese medicine of the present invention.
The present invention treats the 1000 routine hearts, cerebrovascular patient altogether, clinical symptoms: apoplectic hemiplegia, aphasia, facial hemiparalysis, hemiplegia, with after together veiny recover gradually, month person of medication generally recovers self care ability fully, walking is normal, normal, facial hemiparalysis is no more than and 1 week recovered normal in a minute, blood pressure is kept normally, does not stay sequela.Cure rate reaches 99%, effect stability.Cure rate reaches 98%, and total effective rate reaches 100%.
1, the clinical experiment of treatment by Chinese herbs 100 routine coronary heart disease of the present invention and patient with angina pectoris report:
Clinical symptoms: uncomfortable in chest, feel suffocated, angina pectoris.Through taking Chinese medicine of the present invention, coronary heart disease causes in 12 hours has palpitation, breathe hard, symptom such as uncomfortable in chest can be alleviated rapidly, and angina pectoris symptom has clear improvement, and generally takes 3-10 days symptoms obviously to alleviate, and blood pressure stabilization is taken 1-2 the course of treatment, and symptom disappears substantially.
2, treatment by Chinese herbs cerebral thrombus patient 100 examples of the present invention, sign: consciousness, visual disorder; Paresis or hemiplegia, side sensory disturbance partially; Speech disorder; Movement disorder.Take Chinese medicine of the present invention after 30 days spirit be clearly better, trick is strong, the hemiplegic patient can walk with descending, it is normal that language function recovers, take 2-3 the course of treatment after, limbs and language function recover fully, can take a walk in a minute.Cure rate reaches 98%, and total effective rate reaches 100%.
3, treatment by Chinese herbs cerebral arteriosclerosis 100 examples of the present invention, clinical manifestation: comprise neurasthenia symptom, as dizziness, headache, hypomnesis, ability to work decline and autonomic nervous dysfunction etc.Dementia arteriosclerotica mainly shows as spirit, affective disorder.Patient's symptom and sign disappears or the person's of having clear improvement 98 examples, and effectively, patient's symptom obviously alleviates, and sign is improved or clinical symptoms body disappearance person 2 examples, invalid 0 example.Cure rate reaches 98%, and total effective rate reaches 100%.
Claims (2)
1, a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease is characterized in that being made by the crude drug of following weight ratio: Radix Panacis Quinquefolii 5-8%, Radix Astragali 10-16%, XIGUI 3-5%, Caulis Spatholobi 3-5%, Stigma Croci 1-3%, Radix Notoginseng 3-5%, Radix Salviae Miltiorrhizae 4-6%, Rhizoma Chuanxiong 6-12%, Radix Paeoniae Rubra 3-6%, Semen Persicae 3-6%, Ramulus Cinnamomi 3-6%, Hirudo 2-4%, Pheretima 4-6%, Agkistrodon 3-6%, Scorpio 1.5-3%, Scolopendra 1-3%, Fructus Crataegi 3-6%, Ramulus Uncariae Cum Uncis 3-6%, Rhizoma Gastrodiae 2-3%, Radix Curcumae 3-6%, Radix Aucklandiae 1.5-3%, Rhizoma Alismatis 2-3%, Flos Sophorae 3-5%, Radix Sophorae Flavescentis 3-5%, Radix Puerariae 3-5%, Semen Cassiae 3-5%, Moschus 0.1-0.15%, Borneolum Syntheticum 0.8-1.5%.
2, a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease according to claim 1 is characterized in that being made by the crude drug of following weight ratio: Radix Panacis Quinquefolii 6%, the Radix Astragali 12%, XIGUI 3.6%, Caulis Spatholobi 3.6%, Stigma Croci 1.2%, Radix Notoginseng 3.6%, Radix Salviae Miltiorrhizae 5%, Rhizoma Chuanxiong 7.2%, Radix Paeoniae Rubra 3.6%, Semen Persicae 3.6%, Ramulus Cinnamomi 3.6%, Hirudo 2.4%, Pheretima 5%, Agkistrodon 3.6%, Scorpio 1.8%, Scolopendra 1.2%, Fructus Crataegi 3.6%, Ramulus Uncariae Cum Uncis 3.6%, Rhizoma Gastrodiae 2.5%, Radix Curcumae 3.6%, the Radix Aucklandiae 1.8%, Rhizoma Alismatis 2.5%, Flos Sophorae 3.6%, Radix Sophorae Flavescentis 3.6%, Radix Puerariae 3.6%, Semen Cassiae 3.6%, Moschus 0.1%, Borneolum Syntheticum 0.9%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200610151025A CN101020028B (en) | 2006-11-11 | 2006-11-11 | Chinese medicine for treating cardiac and cerebral vascular diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200610151025A CN101020028B (en) | 2006-11-11 | 2006-11-11 | Chinese medicine for treating cardiac and cerebral vascular diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101020028A true CN101020028A (en) | 2007-08-22 |
CN101020028B CN101020028B (en) | 2010-05-19 |
Family
ID=38707955
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200610151025A Expired - Fee Related CN101020028B (en) | 2006-11-11 | 2006-11-11 | Chinese medicine for treating cardiac and cerebral vascular diseases |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101020028B (en) |
Cited By (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102008658A (en) * | 2010-12-10 | 2011-04-13 | 冯学安 | Traditional Chinese medicine capsule for curing cerebral thrombosis |
CN101461875B (en) * | 2009-01-16 | 2011-09-14 | 司淑芳 | Chinese medicinal composition for treating coronary heart disease |
CN101632732B (en) * | 2009-08-25 | 2011-10-26 | 刘卫丽 | Medicine for treating cerebrovascular diseases |
JP2011529860A (en) * | 2008-09-11 | 2011-12-15 | 青▲島▼▲啓▼元生物技▲術▼有限公司 | Drug composition containing ferulic acid and matrine compounds, and production method and use thereof |
CN102293938A (en) * | 2010-06-28 | 2011-12-28 | 陈振宇 | Traditional Chinese medicine oral liquid for treating cerebralthrombosis and preparation method thereof |
CN102475769A (en) * | 2010-11-25 | 2012-05-30 | 陈冠卿 | Synergistic agent for treating hemiplegia |
CN102526446A (en) * | 2012-01-13 | 2012-07-04 | 张居运 | Traditional Chinese medicine composition for treating coronary heart disease and method for preparing medicated wine by utilizing same |
CN102671134A (en) * | 2012-05-23 | 2012-09-19 | 吴翠霞 | Traditional Chinese medicine composition for treating coronary heart disease |
CN102861244A (en) * | 2012-09-19 | 2013-01-09 | 王吉坤 | Traditional Chinese medicine compound for treating cardia-cerebrovascular disease |
CN102872455A (en) * | 2012-09-28 | 2013-01-16 | 贵阳中医学院 | Medicament for preventing in-stent restenosis after coronary stent implantation and preparation method |
CN102940668A (en) * | 2012-10-31 | 2013-02-27 | 成都医路康医学技术服务有限公司 | Medicine composition for treating cardia-cerebrovascular diseases |
CN103041292A (en) * | 2012-11-29 | 2013-04-17 | 宁国市中医肿瘤医院 | Traditional Chinese medicine for treating apoplexy |
CN103083582A (en) * | 2013-02-05 | 2013-05-08 | 孟宪兰 | Medicine for treating hyperlipidemia |
CN103110888A (en) * | 2013-01-31 | 2013-05-22 | 胡枫 | Traditional Chinese medicine composition for treating ventricular aneurysms complicated by myocardial infarction and preparation method thereof |
CN103202895A (en) * | 2013-04-25 | 2013-07-17 | 赵彦强 | Spray for treating heart disease |
CN103599457A (en) * | 2013-10-31 | 2014-02-26 | 李孔琳 | Traditional Chinese medicine formula for treating heart disease |
CN103656233A (en) * | 2013-11-16 | 2014-03-26 | 陈冰花 | Chinese medicine composition for preventing and treating cerebral thrombosis and sequela |
CN103690643A (en) * | 2014-01-02 | 2014-04-02 | 唐成育 | Medicine for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
CN103893496A (en) * | 2014-04-24 | 2014-07-02 | 赵迎春 | Traditional Chinese medicine preparation for treating stenocardia and preparation method thereof |
CN103948791A (en) * | 2014-03-28 | 2014-07-30 | 河北御芝林药业有限公司 | Traditional Chinese medicinal composition for reducing blood fat, and preparation method thereof |
CN103999991A (en) * | 2014-06-20 | 2014-08-27 | 山东双营食品有限公司 | Burdock tea and production method thereof |
CN104771561A (en) * | 2014-01-15 | 2015-07-15 | 刘超治 | Traditional Chinese medicine formula for treatment of cardiovascular and cerebrovascular diseases and preparation method thereof |
CN103623361B (en) * | 2013-12-19 | 2015-12-09 | 山东益健药业有限公司 | Be used for the treatment of the Chinese medicine composition of cerebral thrombosis |
EP3020407A1 (en) * | 2013-07-11 | 2016-05-18 | Tasly Pharmaceutical Group Co., Ltd. | Traditional chinese medicine composition, and preparation and application thereof |
EP3020408A4 (en) * | 2013-07-11 | 2017-03-15 | Tasly Pharmaceutical Group Co., Ltd. | Traditional chinese medicine composition, and preparation and application thereof |
CN108434422A (en) * | 2018-05-18 | 2018-08-24 | 重庆跃龙生物制药有限公司 | Chinese medicine composition and preparation method thereof for treating cardiovascular and cerebrovascular disease |
US10626077B2 (en) | 2013-08-29 | 2020-04-21 | Tasly Pharmaceutical Group Co., Ltd. | Salvianolic acid compound T, preparation method therefor, and use thereof |
CN111157643A (en) * | 2020-01-02 | 2020-05-15 | 安徽中医药大学 | Traditional Chinese medicine compound research method for treating ischemic cerebrovascular disease based on HPLC technology |
US11013694B2 (en) | 2013-07-11 | 2021-05-25 | Tasly Pharmaceutical Group Co., Ltd. | Formulation of a micro drop pill and the preparation method thereof |
CN115252716A (en) * | 2022-07-29 | 2022-11-01 | 程广 | A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases and dredging systemic vascular diseases |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103893670B (en) * | 2012-12-26 | 2015-04-08 | 刘药石 | Traditional Chinese medicine pill used for treating cardia-cerebrovascular diseases |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1243719A (en) * | 1998-08-05 | 2000-02-09 | 张天明 | Medicine for treating cardiovascular and cerebrovascular diseases and its preparing process |
CN1059123C (en) * | 1998-10-22 | 2000-12-06 | 张继旭 | Medicine for treating brain apoplexy |
-
2006
- 2006-11-11 CN CN200610151025A patent/CN101020028B/en not_active Expired - Fee Related
Cited By (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011529860A (en) * | 2008-09-11 | 2011-12-15 | 青▲島▼▲啓▼元生物技▲術▼有限公司 | Drug composition containing ferulic acid and matrine compounds, and production method and use thereof |
CN101461875B (en) * | 2009-01-16 | 2011-09-14 | 司淑芳 | Chinese medicinal composition for treating coronary heart disease |
CN101632732B (en) * | 2009-08-25 | 2011-10-26 | 刘卫丽 | Medicine for treating cerebrovascular diseases |
CN102293938B (en) * | 2010-06-28 | 2012-09-26 | 陈振宇 | Traditional Chinese medicine oral liquid for treating cerebralthrombosis and preparation method thereof |
CN102293938A (en) * | 2010-06-28 | 2011-12-28 | 陈振宇 | Traditional Chinese medicine oral liquid for treating cerebralthrombosis and preparation method thereof |
CN102475769A (en) * | 2010-11-25 | 2012-05-30 | 陈冠卿 | Synergistic agent for treating hemiplegia |
CN102008658A (en) * | 2010-12-10 | 2011-04-13 | 冯学安 | Traditional Chinese medicine capsule for curing cerebral thrombosis |
CN102526446A (en) * | 2012-01-13 | 2012-07-04 | 张居运 | Traditional Chinese medicine composition for treating coronary heart disease and method for preparing medicated wine by utilizing same |
CN102671134A (en) * | 2012-05-23 | 2012-09-19 | 吴翠霞 | Traditional Chinese medicine composition for treating coronary heart disease |
CN102861244A (en) * | 2012-09-19 | 2013-01-09 | 王吉坤 | Traditional Chinese medicine compound for treating cardia-cerebrovascular disease |
CN102861244B (en) * | 2012-09-19 | 2014-11-05 | 王吉坤 | Traditional Chinese medicine compound for treating cardia-cerebrovascular disease |
CN102872455A (en) * | 2012-09-28 | 2013-01-16 | 贵阳中医学院 | Medicament for preventing in-stent restenosis after coronary stent implantation and preparation method |
CN102940668A (en) * | 2012-10-31 | 2013-02-27 | 成都医路康医学技术服务有限公司 | Medicine composition for treating cardia-cerebrovascular diseases |
CN103041292B (en) * | 2012-11-29 | 2014-04-09 | 宁国市中医肿瘤医院 | Traditional Chinese medicine for treating apoplexy |
CN103041292A (en) * | 2012-11-29 | 2013-04-17 | 宁国市中医肿瘤医院 | Traditional Chinese medicine for treating apoplexy |
CN103110888A (en) * | 2013-01-31 | 2013-05-22 | 胡枫 | Traditional Chinese medicine composition for treating ventricular aneurysms complicated by myocardial infarction and preparation method thereof |
CN103083582B (en) * | 2013-02-05 | 2014-05-28 | 孟宪兰 | Medicine for treating hyperlipidemia |
CN103083582A (en) * | 2013-02-05 | 2013-05-08 | 孟宪兰 | Medicine for treating hyperlipidemia |
CN103202895A (en) * | 2013-04-25 | 2013-07-17 | 赵彦强 | Spray for treating heart disease |
EP3020407A1 (en) * | 2013-07-11 | 2016-05-18 | Tasly Pharmaceutical Group Co., Ltd. | Traditional chinese medicine composition, and preparation and application thereof |
EP3020408A4 (en) * | 2013-07-11 | 2017-03-15 | Tasly Pharmaceutical Group Co., Ltd. | Traditional chinese medicine composition, and preparation and application thereof |
USRE49050E1 (en) | 2013-07-11 | 2022-04-26 | Tasly Pharmaceutical Group Co., Ltd. | Traditional Chinese medicine composition, and preparation and application thereof |
US11013694B2 (en) | 2013-07-11 | 2021-05-25 | Tasly Pharmaceutical Group Co., Ltd. | Formulation of a micro drop pill and the preparation method thereof |
USRE49035E1 (en) | 2013-07-11 | 2022-04-19 | Tasly Pharmaceutical Group Co., Ltd. | Traditional Chinese medicine composition, and preparation and application thereof |
EP3020407A4 (en) * | 2013-07-11 | 2017-05-03 | Tasly Pharmaceutical Group Co., Ltd. | Traditional chinese medicine composition, and preparation and application thereof |
US10626077B2 (en) | 2013-08-29 | 2020-04-21 | Tasly Pharmaceutical Group Co., Ltd. | Salvianolic acid compound T, preparation method therefor, and use thereof |
CN103599457A (en) * | 2013-10-31 | 2014-02-26 | 李孔琳 | Traditional Chinese medicine formula for treating heart disease |
CN103656233B (en) * | 2013-11-16 | 2016-01-20 | 陈冰花 | A kind of prevention and the Chinese medicine composition for the treatment of cerebral thrombosis and sequela |
CN103656233A (en) * | 2013-11-16 | 2014-03-26 | 陈冰花 | Chinese medicine composition for preventing and treating cerebral thrombosis and sequela |
CN103623361B (en) * | 2013-12-19 | 2015-12-09 | 山东益健药业有限公司 | Be used for the treatment of the Chinese medicine composition of cerebral thrombosis |
CN103690643B (en) * | 2014-01-02 | 2016-03-23 | 唐成育 | A kind of medicine for the treatment of cardiovascular and cerebrovascular disease and preparation method thereof |
CN103690643A (en) * | 2014-01-02 | 2014-04-02 | 唐成育 | Medicine for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
CN104771561A (en) * | 2014-01-15 | 2015-07-15 | 刘超治 | Traditional Chinese medicine formula for treatment of cardiovascular and cerebrovascular diseases and preparation method thereof |
CN103948791A (en) * | 2014-03-28 | 2014-07-30 | 河北御芝林药业有限公司 | Traditional Chinese medicinal composition for reducing blood fat, and preparation method thereof |
CN103948791B (en) * | 2014-03-28 | 2019-11-12 | 河北御芝林药业有限公司 | A kind of Chinese medicine composition of reducing blood lipid and preparation method thereof |
CN103893496A (en) * | 2014-04-24 | 2014-07-02 | 赵迎春 | Traditional Chinese medicine preparation for treating stenocardia and preparation method thereof |
CN103999991A (en) * | 2014-06-20 | 2014-08-27 | 山东双营食品有限公司 | Burdock tea and production method thereof |
CN108434422A (en) * | 2018-05-18 | 2018-08-24 | 重庆跃龙生物制药有限公司 | Chinese medicine composition and preparation method thereof for treating cardiovascular and cerebrovascular disease |
CN111157643A (en) * | 2020-01-02 | 2020-05-15 | 安徽中医药大学 | Traditional Chinese medicine compound research method for treating ischemic cerebrovascular disease based on HPLC technology |
CN115252716A (en) * | 2022-07-29 | 2022-11-01 | 程广 | A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases and dredging systemic vascular diseases |
Also Published As
Publication number | Publication date |
---|---|
CN101020028B (en) | 2010-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101020028B (en) | Chinese medicine for treating cardiac and cerebral vascular diseases | |
CN101690764A (en) | Traditional Chinese medicine for treating cardiac, cerebral and vascular diseases and preparation method thereof | |
CN101168042A (en) | Traditional Chinese medicine preparation for curing cardiovascular and cerebrovascular diseases and preparing method | |
CN1895620A (en) | Chinese-medicinal composition for treating coronary heart disease | |
CN1966004A (en) | Medicament for treating cerebrovascular and cardiovascular disease and apoplexy sequelae | |
CN103463561B (en) | Traditional Chinese medicine composition for treating cerebral thrombosis sequelae | |
CN101002899A (en) | Pure traditional Chinese medicine preparation for treating hemiparalysis | |
CN101168021B (en) | Medicine for treating cardio-cerebral disease | |
CN102626476A (en) | Medicine for treating and preventing ischemic cardiovascular and cerebrovascular diseases | |
CN101306169B (en) | Traditional Chinese medicine for treating cardiovascular and cerebrovascular disease | |
CN103356952B (en) | Chinese medicine composition for treating arrhythmia | |
CN101637571B (en) | Traditional Chinese medicine preparation for treating heart cerebrovascular diseases and preparation method thereof | |
CN101979077B (en) | Traditional Chinese medicine for treating heart cerebrovascular diseases | |
CN104001162A (en) | Medicament for treating cardiac neurosis and preparation method thereof | |
CN103212041B (en) | Chinese medicinal composition treating coronary heart disease | |
CN105770399A (en) | Traditional Chinese medicine composition for treating arrhythmia | |
CN104873685A (en) | Medicine for treating coronary heart disease | |
CN104056080A (en) | Traditional Chinese medicine composition for treating cerebral thrombosis sequelae | |
CN102670718A (en) | Chinese medicine composition for treating cardiovascular and cerebrovascular diseases and preparation method of same | |
CN101396525B (en) | Traditional Chinese medicine preparation for treating cerebrovascular disease | |
CN1238004C (en) | Instant particles 'Tongmaihuonao' for invigorating pulse beat and promoting circulation of cerebral blood | |
CN104116948A (en) | A traditional Chinese medicine preparation for preventing and treating cardiac and cerebrovascular disease in the elderly and a preparing method thereof | |
CN117442679A (en) | Ginseng and seven-element medicinal composition for preventing and treating coronary heart disease | |
CN101843645B (en) | Chinese medicament for treating tachycardia | |
CN101234175A (en) | Chinese medicine thrombolysis paralysis-treating granule for treating acute cerebral infarction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100519 Termination date: 20111111 |